Skip to main content
padlock icon - secure page this page is secure

2-Substituted-5-Nitroheterocycles: In Vitro Anti-Helicobacter pylori Activity and Structure-Activity Relationship Study

Buy Article:

$68.00 + tax (Refund Policy)

Helicobacter pylori infection is the main cause of gastritis and gastroduodenal ulcer disease, and is associated with gastric cancer. In order to develop new potential anti-Helicobacter pylori candidates, we have investigated the antimicrobial activity of some 2-substituted-5-nitroheterocycles against H. pylori. The anti-Helicobacter pylori activity of selected compounds along with commercially available antibacterial metronidazole was evaluated by comparing the inhibition zone diameters determined using the paper disc diffusion bioassay. The compounds that exhibited strong anti-H. pylori activity at concentration of 8-32 μg/disc (average of inhibition zone >20 mm) were further tested against 20 clinical isolates of H. pylori at lower concentrations. In general, we have identified a series of 5-nitroheterocyles including nitrofurans, nitrothiophenes and nitroimidazoles bearing a carboxaldehyde thiosemicarbazone or 2-substituted-1,3,4- thiadiazole residues in the 2-position of the 5-nitroheteroaryl ring as potent anti- Helicobacter pylori agents. It was found that chloro-/ amino-/ mercapto-substituted 1,3,4-thiadiazole moiety attached to 5-nitroheteroaryl ring served as promising C-2 substituents for 2-substituted-5-nitroheterocycles. The Structure-activity relationship of this series indicates that both the structure of the nitroaryl scaffold and the C-2 attached residue have dramatic impact on anti-Helicobacter pylori activity.

No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: 1,3,4-thiadiazole; 5-nitrofuran; 5-nitroimidazole; 5-nitrothiophene; Antibacterial activity; Helicobacter pylori

Document Type: Research Article

Publication date: November 1, 2009

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more